Cord blood KL-6, a specific lung injury marker, correlates with the subsequent development and severity of atypical bronchopulmonary dysplasia

Neonatology

Volumn 93, Issue 4, 2008, Pages 223-229

  Kim, Do Hyun ^a   Kim, Han Suk ^a   Shim, So Yeon ^b   Lee, Jin A ^a   Choi, Chang Won ^a   Kim, Ee Kyung ^a   Kim, Beyong Il ^a   Choi, Jung Hwan ^a  

^a Seoul National University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

Author keywords

Antenatal risk factor; C reactive protein; Chronic lung disease; Intrauterine inflammatory response; Pathogenesis, bronchopulmonary dysplasia

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN; PROTEIN KL 6;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; LUNG DYSPLASIA; LUNG INJURY; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; C-REACTIVE PROTEIN; CA-15-3 ANTIGEN; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE;

EID: 44849110655     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000111100     Document Type: Article

References (26)

1. Northway WH Jr, Rosan RC, Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967;276:357-368.
2. Bancalari E, Claure N, Sosenko IR: Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003;8:63-71.
3. Kinsella JP, Greenough A, Abman SH: Bronchopulmonary dysplasia. Lancet 2006;367:1421-1431.
4. Jobe AJ: The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-643.
5. Charafeddine L, D'Angio CT, Phelps DL: Atypical chronic lung disease patterns in neonates. Pediatrics 1999;103:759-765.
6. Fujimura M, Takeuchi T, Ando M, Funato M, Shimada S, Tsujimoto A, Kanaya S, Kozuki K, Morinoto S: Elevated immunoglobulin M levels in low birth-weight neonates with chronic respiratory insufficiency. Early Hum Dev 1983;9:27-32.
7. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK: A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773-779.
8. Speer CP: Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003;8:29-38.
9. Panickar J, Scholefield H, Kumar Y, Pilling DW, Subhedar NV: Atypical chronic lung disease in preterm infants. J Perinat Med 2004;32:162-167.
10. Kohno N: Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 1999;46:151-158.
11. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M: Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18:203-216.
12. Ogihara T, Hirano K, Morinobu T, Ogawa S, Hiroi M, Ban R Ogihara H, Tamai H: KL-6, a mucinous glycoprotein, as an indicator of chronic lung disease of the newborn. J Pediatr 2000;137:280-282.
13. Ogihara T, Hirano K, Morinobu T, Kim HS, Ogawa S, Hiroi M, Oue S, Ban R, Hira S, Hasegawa M, Yamaoka S, Yasui M: Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia. Pediatr Res 2006;60:613-618.
14. Yoon BH, Romero R, Shim JY, Shim SS, Kim CJ, Jun JK: C-reactive protein in umbilical cord blood: a simple and widely available clinical method to assess the risk of amniotic fluid infection and funisitis. J Matern Fetal Neonatal Med 2003;14:85-90.
15. Jobe AH, Bancalari E: NICHD/NHLBI/ORD Workshop summary; Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
16. Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, Syn HC: Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995;172:960-970.
17. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, Jun JK: The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000;183:1124-1129.
18. Kraybill EN, Runyan DK, Bose CL, Khan JH: Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr 1989;115:115-120.
19. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G: Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-610.
20. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM; North Carolina Neonatologists Association: Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 1999;104:1345-1350.
21. Ishizaka A, Matsuda T, Albertine KH, Koh H, Tasaka S, Hasegawa N, Kohno N, Kotani T, Morisaki H, Takeda J, Nakamura M, Fang X, Martin TR, Matthay MA, Hashimoto S: Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004;286:L1088-L1094.
22. Kent A, Dahlstrom JE: Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia. J Paediatr Child Health 2004;40:356-359.
23. Kramer BW, Jobe AH: The clever fetus: responding to inflammation to minimize lung injury. Biol Neonate 2005;88:202-207.
24. Watterberg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-215.
25. Watterberg KL, Scott SM, Naeye RL: Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants. Pediatrics 1997;99:e6.
26. Willet KE, Kramer BW, Kallapur SG, Ikegami M, Newnham JP, Moss TJ, Sly PD, Jobe AH: Intra-amniotic injection of IL-1 induces inflammation and maturation in fetal sheep lung. Am J Physiol Lung Cell Mol Physiol 2002;282:L411-L420.